Design and synthesis of 4-(α-hydroxymalonyl)phenylalanine as a new phosphotyrosyl mimetic and its use in growth factor receptor bound 2 Src-homology 2 (Grb2 SH2) domain-binding peptides

Sang Uk Kang, Karen M. Worthy, Lakshman K. Bindu, Manchao Zhang, Dajun Yang, Robert J. Fisher, Terrence R. Burke

    Research output: Contribution to journalArticlepeer-review

    10 Scopus citations

    Abstract

    A new phosphotyrosyl mimetic 4-(α-hydroxymalonyl)phenylalanine and its incorporation into a Grb2 SH2 domain-binding tripeptide are presented. In whole-cell studies using malonyl ethyl ester prodrug derivatives, it was observed that the 4-(α-hydroxymalonyl)phenylalanyl-containing peptide exhibited greater efficacy than the nonhydroxylated 4-(malonyl)phenylalanyl- containing congener in blocking the association of Grb2 with activated erbB-2 tyrosine kinase. These results are consistent with de-esterification and at least partial intracellular decarboxylation.

    Original languageEnglish (US)
    Pages (from-to)5369-5372
    Number of pages4
    JournalJournal of Medicinal Chemistry
    Volume48
    Issue number16
    DOIs
    StatePublished - Aug 11 2005

    ASJC Scopus subject areas

    • Molecular Medicine
    • Drug Discovery

    Fingerprint

    Dive into the research topics of 'Design and synthesis of 4-(α-hydroxymalonyl)phenylalanine as a new phosphotyrosyl mimetic and its use in growth factor receptor bound 2 Src-homology 2 (Grb2 SH2) domain-binding peptides'. Together they form a unique fingerprint.

    Cite this